UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

L'attraction des places financières internationales

Revue d'économie financière, 1992, Vol.21 (2), p.217-227

1992

Volltextzugriff (PDF)

L'attraction des places financières internationales

Revue d'économie financière, 1992-07 (21), p.217-227

1992

Volltextzugriff (PDF)

Ten-year trends in the incidence and treatment of cardiogenic shock

Annals of internal medicine, 2008-11, Vol.149 (9), p.618

2008

Volltextzugriff (PDF)

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

The Lancet (British edition), 2018-09, Vol.392 (10150), p.849-856

2018

Volltextzugriff (PDF)

Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial

The Lancet (British edition), 2020-11, Vol.396 (10261), p.1504-1510

2020

Volltextzugriff (PDF)

Infective endocarditis: prevention and antibiotic prophylaxis

Swiss medical weekly, 2021-02, Vol.151 (708), p.w20473

2021

Volltextzugriff (PDF)

Coronary Artery Disease Progression Late After Successful Stent Implantation

Journal of the American College of Cardiology, 2012-02, Vol.59 (9), p.793-799

2012

Volltextzugriff (PDF)

Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II

PloS one, 2019-01, Vol.14 (1), p.e0210821-e0210821

2019

Volltextzugriff (PDF)

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents

Journal of the American College of Cardiology, 2006-12, Vol.48 (12), p.2584

2006

Volltextzugriff (PDF)

Letter by Jeger and Pfisterer regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement"

Circulation (New York, N.Y.), 2015-09, Vol.132 (13), p.e165-e165

2015

Volltextzugriff (PDF)

Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction

The New England journal of medicine, 2023-10, Vol.389 (15), p.1368-1379

2023

Volltextzugriff (PDF)

Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries

The New England journal of medicine, 2010-12, Vol.363 (24), p.2310-2319

2010

Volltextzugriff (PDF)

Prolonged dual antiplatelet therapy in renal failure: a challenging trade-off

Journal of thoracic disease, 2015-12, Vol.7 (12), p.E625-E628

2015

Volltextzugriff (PDF)

Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysis

The Lancet (British edition), 2007-11, Vol.370 (9598), p.1552-1559

2007

Volltextzugriff (PDF)

Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial

Journal of the American Heart Association, 2020-10, Vol.9 (20), p.e017434

2020

Volltextzugriff (PDF)

Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations

The American heart journal, 2014-11, Vol.168 (5), p.698-705.e2

2014

Volltextzugriff (PDF)

Infektiöse Endokarditis: Prävention und Prophylaxe

Swiss medical forum, 2021-02

2021

Volltextzugriff (PDF)

Prognostic value of "routine" cardiac stress imaging 5 years after percutaneous coronary intervention: the prospective long-term observational BASKET (Basel Stent Kosteneffektivitäts Trial) LATE IMAGING study

JACC. Cardiovascular interventions, 2014-06, Vol.7 (6), p.615-621

2014

Volltextzugriff (PDF)

Predictors and prognostic impact of silent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus

International journal of cardiology, 2017-10, Vol.244, p.37-42

2017

Volltextzugriff (PDF)

Frequency of Cardiac Death and Stent Thrombosis in Patients with Chronic Obstructive Pulmonary Disease Undergoing Percutaneous Coronary Intervention (From the BASKET-PROVE I and II Trials)

The American journal of cardiology, 2017-01, Vol.119 (1), p.14-19

2017

Volltextzugriff (PDF)

No one-size-fits-all: A tailored approach to antithrombotic therapy after stent implantation

Circulation (New York, N.Y.), 2012-01, Vol.125 (3), p.471-473

2012

Volltextzugriff (PDF)

Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy

JACC. Cardiovascular imaging, 2014-10, Vol.7 (10), p.1001-1010

2014

Volltextzugriff (PDF)

Duration of dual antiplatelet therapy after drug-eluting stents

The New England journal of medicine, 2015-04, Vol.372 (14), p.1372

2015

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(78)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

L'attraction des places financières internationales

L'attraction des places financières internationales

Ten-year trends in the incidence and treatment of cardiogenic shock

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial

Infective endocarditis: prevention and antibiotic prophylaxis

Coronary Artery Disease Progression Late After Successful Stent Implantation

Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents

Letter by Jeger and Pfisterer regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement"

Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction

Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries

Prolonged dual antiplatelet therapy in renal failure: a challenging trade-off

Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysis

Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial

Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations

Infektiöse Endokarditis: Prävention und Prophylaxe

Prognostic value of "routine" cardiac stress imaging 5 years after percutaneous coronary intervention: the prospective long-term observational BASKET (Basel Stent Kosteneffektivitäts Trial) LATE IMAGING study

Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial

Predictors and prognostic impact of silent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus

Frequency of Cardiac Death and Stent Thrombosis in Patients with Chronic Obstructive Pulmonary Disease Undergoing Percutaneous Coronary Intervention (From the BASKET-PROVE I and II Trials)

Guidance on the use of the weight of evidence approach in scientific assessments

No one-size-fits-all: A tailored approach to antithrombotic therapy after stent implantation

Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy

Duration of dual antiplatelet therapy after drug-eluting stents

Suchergebnisse filtern